Results 41 to 50 of about 15,009 (224)

Nephroprotective and Anti-Diabetic Potential of Beta vulgaris L. Root (Beetroot) Methanolic Extract in a Rat Model of Type 2 Diabetes Mellitus

open access: yesMedicina
Background and Objectives: Diabetes mellitus is a chronic metabolic disease associated with several complications, including that of kidney disease. Plant-based dietary products have shown promise in mitigating these effects to improve kidney function ...
Laila Naif Al-Harbi   +7 more
doaj   +1 more source

Attenuation of cisplatin-induced nephrotoxicity by ethanol extract of seeds of Lens culinaris medik

open access: yesAncient Science of Life, 2017
Aim: The present study was undertaken to evaluate the potential role of ethanol extract of seeds of Lens culinaris in attenuation of Cisplatin-induced nephrotoxicity in male Albino rats.
Adikay Sreedevi, Kaveripakam Saisruthi
doaj   +1 more source

Albumin-induced apoptosis of tubular cells is modulated by BASP1 [PDF]

open access: yes, 2015
Albuminuria promotes tubular injury and cell death, and is associated with faster progression of chronic kidney disease (CKD) to end-stage renal disease.
Cannata, Pablo   +9 more
core   +2 more sources

Nephroprotective Effects of Selenium Nanoparticles Against Sodium Arsenite-Induced Damages

open access: yesInternational Journal of Nanomedicine, 2023
Shubin Li, Xingna Dong, Limeng Xu, Zhenli Wu Department of Geriatric Medical Center, Inner Mongolia People’s Hospital, Hohhot, 010021, People’s Republic of ChinaCorrespondence: Zhenli Wu, Email zhenliwu@126.comIntroduction: The potential effects of ...
Li S, Dong X, Xu L, Wu Z
doaj  

Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats [PDF]

open access: yes, 2019
Male Cy/+ rats have shown a relatively consistent pattern of progressive kidney disease development that displays multiple key features of late stage chronic kidney disease-mineral bone disorder (CKD-MBD), specifically the development of cortical bone ...
Allen, Matthew R.   +7 more
core   +1 more source

Nephroprotection in Diabetes Mellitus

open access: yesClinical and Experimental Hypertension, 1999
Present study analyses nephroprotective effect of various therapeutic interventions at different stages of kidney involvement in diabetes mellitus. A MEDLINE search of past 10 years data on various experimental studies, controlled clinical trials, meta-analysis and editorials pertaining to nephroprotection in diabetes mellitus was made.
openaire   +2 more sources

Hypolipidemic, hepatoprotective, nephroprotective and anti-lipid peroxidation properties of a methanol extract of Paullinia pinnata root-bark, in alloxan-induced hyperglycemic rats

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2019
This study evaluated the hypolipidemic, hepatoprotective, nephroprotective and anti-lipid peroxidation properties of a methanol extract of Paullinia pinnata root-bark, in alloxan-induced hyperglycemic rats. The extract of P.
Onoja Samuel O.   +7 more
doaj   +1 more source

Phytochemical Profile, Antioxidant, Cardioprotective and Nephroprotective Activity of Romanian Chicory Extract

open access: yesPlants, 2020
The present study analyzed the methanol extract and tincture obtained from the spontaneous Romanian Cichorium intybus species, in order to evaluate polyphenols content and some biological properties.
Alexandra Epure   +7 more
doaj   +1 more source

Molecular mechanisms underlying the nephroprotective effects of PACAP in diabetes [PDF]

open access: yes, 2014
Diabetic nephropathy is the leading cause of end-stage renal failure and accounts for 30-40% of patients entering renal transplant programmes. Nephroprotective effects of the neuropeptide PACAP38 against diabetes has been shown previously, but the ...
Bánki, Eszter   +10 more
core   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy